R. Norvilaitė

The impact of CYP2C19 and CYP4F2 variants and clinical factors on treatment outcomes during antiplatelet therapy.

V. Lesauskaitė, J. Jurgaityte, Vacis Tatarunas, 2019, Pharmacogenomics.

Blood direct PCR: impact of CYP2C19 and CYP4F2 variants for bleeding prediction in ST-elevation myocardial infarction patients with ticagrelor.

V. Lesauskaitė, G. Sakalyte, J. Venius, 2022, Personalized medicine.